NEW YORK (GenomeWeb News) - Sequenom said today that MetaMorphix will expand its use of Sequenom’s MassARRAY and iPlex technologies for its genotyping and selection services.
 
The agreement extends an earlier partnership that the companies signed in 2005.
 
The new agreement will allow MMI to handle increased sample orders coming from its DNA-based livestock and companion animal diagnostic products, Sequenom said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.